BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 29532580)

  • 21. Lamivudine use in pregnant HBsAg-females effectively reduces maternal viremia.
    Foaud HM; Maklad S; Gmal El Din A; Mahmoud F
    Arab J Gastroenterol; 2019 Mar; 20(1):8-13. PubMed ID: 30857834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes.
    Chen HL; Lee CN; Chang CH; Lai MW; Tsai MC; Mu SC; Liu CJ; Shih JC; Wen WH; Hu RT; Huang CP; Hu KC; Chen CP; Lee CL; Chien RN; Chang KC; Hsu HY; Lee CC; Ni YH; Chang MH
    Liver Int; 2024 Jun; 44(6):1422-1434. PubMed ID: 38456620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.
    ; Dionne-Odom J; Tita AT; Silverman NS
    Am J Obstet Gynecol; 2016 Jan; 214(1):6-14. PubMed ID: 26454123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
    Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y
    Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection.
    Wen WH; Huang CW; Chie WC; Yeung CY; Zhao LL; Lin WT; Wu JF; Ni YH; Hsu HY; Chang MH; Lin LH; Chen HL
    Hepatology; 2016 Nov; 64(5):1451-1461. PubMed ID: 27044007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: A large prospective cohort study in China.
    Lu Y; Zhu FC; Liu JX; Zhai XJ; Chang ZJ; Yan L; Wei KP; Zhang X; Zhuang H; Li J
    Vaccine; 2017 Dec; 35(48 Pt B):6627-6633. PubMed ID: 29079104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China.
    Cui F; Woodring J; Chan P; Xu F
    Int J Epidemiol; 2018 Oct; 47(5):1529-1537. PubMed ID: 29757383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
    Celen MK; Mert D; Ay M; Dal T; Kaya S; Yildirim N; Gulsun S; Barcin T; Kalkanli S; Dal MS; Ayaz C
    World J Gastroenterol; 2013 Dec; 19(48):9377-82. PubMed ID: 24409065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative Hepatitis B Surface Antigen Predicts Hepatitis B Transmission in Infants Born to e Antigen-positive Mothers.
    Peng S; Wan Z; Liu T; Wang Y; Chen H; Li X; Du Y
    J Clin Gastroenterol; 2020 Jan; 54(1):76-82. PubMed ID: 30575631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load.
    Wang M; Bian Q; Zhu Y; Pang Q; Chang L; Li R; Tiongson BC; Zhang H; Pan CQ
    Aliment Pharmacol Ther; 2019 Jan; 49(2):211-217. PubMed ID: 30506691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study.
    van Schalkwyk J; Nourmoussavi M; Massey A; Gustafson R; Brodkin E; Petric M; Krajden M; Dobson S; Buxton J; Bigham M; Pick N; Schreiber R; Sherlock CH; Money D; Yoshida EM
    Can J Gastroenterol Hepatol; 2014 Nov; 28(10):525-8. PubMed ID: 25390612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants.
    Singh AE; Plitt SS; Osiowy C; Surynicz K; Kouadjo E; Preiksaitis J; Lee B
    J Viral Hepat; 2011 Jul; 18(7):468-73. PubMed ID: 20546502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of hepatitis B immunoglobulin in prevention of mother-to-child transmission of chronic hepatitis B in HBsAg- and HBeAg-positive mother.
    Wang H; Fang JW; Gu ZW; Song DJ; Chen Y; Chen GD; Zhao B; Sun C; Ma Y; Wang KX; Shen JQ; Yang XF; Luo Q
    J Obstet Gynaecol; 2022 Jul; 42(5):877-882. PubMed ID: 34569426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Predictive study of HBsAg in different stages of neonatal venous blood on failure of blocking HBV mother to infant transmission].
    Yi W; Li MH; Hu YH; Liu F; Zhang YL; Liu XJ; Hao HX; Song SJ; Liu Y; Li XH; Sun JY; Liu M; Cheng J; Xie Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):338-41. PubMed ID: 22338218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
    Sellier PO; Maylin S; Berçot B; Chopin D; Lopes A; Simoneau G; Evans J; Delcey V; Bénifla JL; Simon F; Bergmann JF
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):259-263. PubMed ID: 27879486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations.
    Ayres A; Yuen L; Jackson KM; Manoharan S; Glass A; Maley M; Yoo W; Hong SP; Kim SO; Luciani F; Bowden DS; Bayliss J; Levy MT; Locarnini SA
    J Viral Hepat; 2014 Nov; 21(11):809-17. PubMed ID: 24329944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa.
    Mokaya J; Burn EAO; Tamandjou CR; Goedhals D; Barnes EJ; Andersson M; Pinedo-Villanueva R; Matthews PC
    BMC Public Health; 2019 Jun; 19(1):829. PubMed ID: 31242901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.
    Zhu B; Lv X; Zhao Z; Chen L; Chen X; Li C; Li S; Dai E
    Medicine (Baltimore); 2021 Nov; 100(44):e27695. PubMed ID: 34871254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women.
    Sun KX; Li J; Zhu FC; Liu JX; Li RC; Zhai XJ; Li YP; Chang ZJ; Nie JJ; Zhuang H
    Vaccine; 2012 Aug; 30(36):5335-40. PubMed ID: 22749833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A retrospective study of hepatitis B mother-to-child transmission prevention and postvaccination serological test results of infants at risk of perinatal transmission in two counties of middle China.
    Yonghao G; Pumei D; Jianhui Y; Jin X; Yanyang Z; Zhe W
    J Viral Hepat; 2017 Aug; 24(8):687-695. PubMed ID: 28199772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.